Selected Publications

  • Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014;174(12):1974-81. PMCID: PMC4506774.
  • Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Mao J, Edwards RR, Samet JH. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Drug Alcohol Depend. 2015;153:286-92. PMCID: PMC4509826.
  • Carey K, Huang W, Linas BP, Tsui JI. Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office-based program for opioid use disorders. J Subst Abuse Treat. 2016 Jul;66:54–9. PMCID: PMC5097249.
  • Tsui JI, Williams EC, Green PK, Berry K, Su F Ioannou GN. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Drug Alcohol Depend. 2016 Dec 1;169:101-109. PMID: 27810652.
  • Tsui JI, Burt R, Thiede H, Glick SN. Utilization of buprenorphine and methadone among opioid users who inject drugs. Subst Abus. 2018 Jan 2;39(1):83–88. PMID: 28796591.
  • Gnatienko, N, Wagman JA, Cheng MD, Bazzi A, Raj A, Blokhina E, Toussova O, Forman LS, Lioznov D, Bridden C, Sullivan M, Bryant K, Samet JH, Tsui JI. Serodiscordant Partnerships and Opportunities for Pre-exposure Prophylaxis among Partners of Women and Men Living with HIV in St. Petersburg, Russia. PLoS One. 2018 Nov 16;13(11). PMID: 30444903 PMCID: PMC6239322.

 View a full list of Dr. Tsui's publications or her CV.


  • “Addressing Treatment Gaps to Overcome the Crisis of Opioid Use Disorders and Hepatitis C” at the University of Washington School of Medicine, Department of Medicine Grand Rounds, May 30, 2019, Seattle, WA. Recorded Presentation.

Cited in the Popular Press